Biopharmaceutical Compositions

Patent No. EP3341409 (titled "Biopharmaceutical Compositions") was filed by Glaxosmithkline on Aug 22, 2016. The application was issued on Feb 25, 2026.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ABEL & IMRAYNov 18, 2026ABEL & IMRAY

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3341409

GLAXOSMITHKLINE
Application Number
EP16760801A
Filing Date
Aug 22, 2016
Status
Granted And Under Opposition
Jan 23, 2026
Publication Date
Feb 25, 2026